Cost-Effectiveness of Introducing Pneumococcal Vaccination Programme: Including: Economic Burden of Pneumococcal Diseases and Acute Otitis Media - Couverture souple

Aljunid, Syed Mohamed; Maimaiti, Namaitijiang

 
9783330973473: Cost-Effectiveness of Introducing Pneumococcal Vaccination Programme: Including: Economic Burden of Pneumococcal Diseases and Acute Otitis Media
Couverture souple
ISBN 10 : 3330973471 ISBN 13 : 9783330973473
Editeur : Noor Publishing, 2017

Synopsis

Pneumococcal disease is one of the important public health issues worldwide. The World Health Organisation estimates that 1.6 million people die every year from this disease, 0.7–1 million of which are children aged less than 5 years.This book reports the outcome of a study to determine the clinical and cost burden of pneumococcal disease in Malaysia and to evaluate the economic impact of introducing Pneumococcal Vaccine in the National Immunisation Programme for the prevention of invasive and non-invasive pneumococcal diseases. A retrospective review of patient medical records from four public hospitals in Malaysia was conducted to quantify the cost and the number of paediatric and adult hospital admissions attributable to pneumococcal pneumonia, septicaemia, meningitis and acute otitis media. A total 2.3 million cases of pneumococcal diseases were estimated in Malaysian annually. The cost-effectiveness analysis using Markov cohort model predicted that the vaccine would to lead to a significant reduction in the incidence of all manifestations of pneumococcal diseases, and importantly will save lives of adults and children.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Pneumococcal disease is one of the important public health issues worldwide. The World Health Organisation estimates that 1.6 million people die every year from this disease, 0.7–1 million of which are children aged less than 5 years.This book reports the outcome of a study to determine the clinical and cost burden of pneumococcal disease in Malaysia and to evaluate the economic impact of introducing Pneumococcal Vaccine in the National Immunisation Programme for the prevention of invasive and non-invasive pneumococcal diseases. A retrospective review of patient medical records from four public hospitals in Malaysia was conducted to quantify the cost and the number of paediatric and adult hospital admissions attributable to pneumococcal pneumonia, septicaemia, meningitis and acute otitis media. A total 2.3 million cases of pneumococcal diseases were estimated in Malaysian annually. The cost-effectiveness analysis using Markov cohort model predicted that the vaccine would to lead to a significant reduction in the incidence of all manifestations of pneumococcal diseases, and importantly will save lives of adults and children.

Biographie de l'auteur

Dr Syed Mohamed Aljunid is currently appointed as the Founding Professor in the Department of Health Policy and Management, Faculty of Public Health, Kuwait University. Prior to this he served as Professor of Health Economics and Public Health Medicine in National University of Malaysia and the International Centre for Casemix and Clinical Coding.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
Noor Publishing
Date d'édition
2017
Langue
anglais
ISBN 10 
3330973471
ISBN 13 
9783330973473
Reliure
Broché
Nombre de pages
216
Coordonnées du fabricant
non disponible
Personne responsable
non disponible